Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term complications of cosmetic iris implants. | BMC Ophthalmol | 2022 | 36451122 | PubTator, text mining | PubMed |
| Choroidal neo-vascular membrane in a paediatric optic disc pit: A case report. | Am J Ophthalmol Case Rep | 2022 | 36439653 | PubTator, text mining | PubMed |
| Involvement of Transporters in Intestinal Drug-Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time. | Pharmaceutics | 2022 | 36432682 | PubTator, text mining | PubMed |
| Interaction of Masitinib with Organic Cation Transporters. | Int J Mol Sci | 2022 | 36430667 | PubTator, text mining | PubMed |
| The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity. | Int J Mol Sci | 2022 | 36430444 | PubTator, text mining | PubMed |
| Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance. | Cells | 2022 | 36429078 | PubTator, text mining | PubMed |
| Novel Compound Heterozygous Variations in MPDZ Gene Caused Isolated Bilateral Macular Coloboma in a Chinese Family. | Cells | 2022 | 36429029 | PubTator, text mining | PubMed |
| Association between SEMA3A signaling pathway genes and BMD/OP risk: An epidemiological and experimental study. | Front Endocrinol (Lausanne) | 2022 | 36425469 | PubTator, text mining | PubMed |
| The Effect of Using Reactive Agility Exercises with the FITLIGHT Training System on the Speed of Visual Reaction Time and Dribbling Skill of Basketball Players. | Sports (Basel) | 2022 | 36422946 | PubTator, text mining | PubMed |
| A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment. | Front Aging Neurosci | 2022 | 36420311 | PubTator, text mining | PubMed |
| Early choroidal changes detected by swept-source OCT in type 2 diabetes and their association with diabetic kidney disease. | BMJ Open Diabetes Res Care | 2022 | 36418057 | PubTator, text mining | PubMed |
| Polypoidal choroidal vasculopathy-characteristics and response to treatment with bevacizumab in caucasian patients. | Int J Retina Vitreous | 2022 | 36414995 | PubTator, text mining | PubMed |
| Transient ciliochoroidal detachment after microhook ab interno trabeculotomy: Its frequency and potential risk factors. | Front Med (Lausanne) | 2022 | 36405623 | PubTator, text mining | PubMed |
| Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab. | Int J Retina Vitreous | 2022 | 36397121 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals the communications between extracellular matrix-related components and Schwann cells contributing to the earlobe keloid formation. | Front Med (Lausanne) | 2022 | 36388926 | PubTator, text mining | PubMed |
| Optical diagnostic imaging and therapy for thyroid cancer. | Mater Today Bio | 2022 | 36388462 | PubTator, text mining | PubMed |
| Advances in multi-omics study of biomarkers of glycolipid metabolism disorder. | Comput Struct Biotechnol J | 2022 | 36382190 | PubTator, text mining | PubMed |
| Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report. | BMC Ophthalmol | 2022 | 36376841 | PubTator, text mining | PubMed |
| Recent advances on small molecules in osteogenic differentiation of stem cells and the underlying signaling pathways. | Stem Cell Res Ther | 2022 | 36371202 | PubTator, text mining | PubMed |
| Synthesis and Anticancer Activity of Indole-Functionalized Derivatives of Betulin. | Pharmaceutics | 2022 | 36365190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=40